CD19/CD20 Double Knockout Raji Cell Line

CD19/CD20 Double Knockout Raji Cell Line
Item number Size Datasheet Manual SDS Delivery time Quantity Price
BPS-82623 2 vials - -

3 - 8 business days*

9,897.00€
 
CD19/CD20 Double Knockout Raji Cell Line is a Raji cell line where CD19 (Cluster of... more
Product information "CD19/CD20 Double Knockout Raji Cell Line"
CD19/CD20 Double Knockout Raji Cell Line is a Raji cell line where CD19 (Cluster of Differentiation 19, B-lymphocyte surface antigen B4, or CVID3) and CD20 (B-lymphocyte antigen CD20, or MS4A1) have been genetically removed from Raji cells using CRISPR/Cas9 genome editing. This cell line has been validated by genome sequencing and flow cytometry.
Keywords: CD19, B-lymphocyte antigen CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte surface antigen B4,
Supplier: BPS Bioscience
Supplier-Nr: 82623

Properties

Application: CAR-T / NK co-culture killing assay control
Species reactivity: human

Handling & Safety

Storage: Liquid nitrogen
Shipping: -80°C (International: °C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "CD19/CD20 Double Knockout Raji Cell Line"
Write a review
or to review a product.
Viewed